We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,054

Patent Box probe retracted

  • Dehns
  • -
  • European Union, United Kingdom
  • -
  • February 26 2015

The European Commission have announced that they have withdrawn their investigation into the UK's Patent Box Scheme. The Commission were previously

The CJEU on the interpretation of the Specific Mechanism

  • Clifford Chance LLP
  • -
  • European Union
  • -
  • February 24 2015

Introduction On 12 February 2015, the Court of Justice of the European Union ("CJEU") delivered its decision in Merck Canada v Sigma Pharmaceuticals

Importazione parallela di medicinali brevettati dai “nuovi” Stati UE: la Corte di Giustizia spiega il Neccanismo Specifico

  • Martini Manna Avvocati
  • -
  • European Union
  • -
  • February 20 2015

La Corte di Giustizia UE (“CGUE”) ha recentemente chiarito il funzionamento del c.d. “Meccanismo Specifico” che regola l’importazione parallela

The parallel import of patented drugs from “new” EU Member States: the ECJ explains the Specific Mechanism

  • Martini Manna Avvocati
  • -
  • European Union
  • -
  • February 20 2015

The European Court of Justice (“ECJ”) recently clarified the function of the “Specific Mechanism” regulating the parallel import of Patented drugs

EPO receives a record 273 000 patent filings in 2014, up by around 3

  • Unitalen
  • -
  • European Union
  • -
  • February 19 2015

The European Patent Office (EPO) received more than 273 110 patent filings in 2014, an increase of around 3 over 2013, and a new all-time high

To opt-out, or not to opt-out, that is the question

  • FRKelly
  • -
  • European Union
  • -
  • February 18 2015

The third article in this series considered the significance of Ireland hosting a local division of the Unified Patent Court (UPC). This fourth

Overcoming inventive step objections at the EPO

  • Marks & Clerk
  • -
  • European Union
  • -
  • February 17 2015

Specifying a therapeutic effect in a product claim may not be helpful in overcoming an objection of inventive step, according to a recent EPO Board

The oppositions and appeals process at the EPO - a case study

  • Marks & Clerk
  • -
  • European Union
  • -
  • February 17 2015

The opposition procedure available at the European Patent Office (EPO) provides third parties with an opportunity to contest a patent for nine months

CJEU judgment on Merck Canada Inc. & Merck Sharp & Dohme Ltd v Sigma Pharmaceuticals plc, case C-53913, 12 February 2015

  • Hogan Lovells
  • -
  • European Union
  • -
  • February 16 2015

The CJEU has recently clarified when patent and SPC rights can be relied on under the Specific Mechanism to prevent parallel imports within the EU

More from the CJEU on SPCs and active ingredients

  • Taylor Wessing
  • -
  • European Union
  • -
  • February 16 2015

Arne Forsgren v Österreichisches Patentamt (CJEU Case C 63113), concerns Forsgren's application to the Austrian authorities for an SPC for Protein D